T1	Participants 92 148	patients with standard-risk acute lymphoblastic leukemia
T2	Participants 219 263	childhood acute lymphoblastic leukemia (ALL)
T3	Participants 525 548	more than 1000 subjects
T4	Participants 618 675	Children with National Cancer Institute standard-risk ALL
